Product
Betaine
Name
Betaine
INN Name
betaine
FDA Approved
Yes
3 clinical trials
3 organizations
5 indications
3 documents
Indication
SyringomyeliaIndication
Hepatitis CIndication
Genotype 1Indication
RelapseIndication
HomocystinuriaClinical trial
The Effect of Betaine in Refractory Syringomyelia（RS）Status: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
Pilot Therapy Using Betaine in Combination With Peginterferon Alpha-2a Plus Ribavirin in Subjects With Genotype 1 Hepatitis C Who Have Not Achieved a Sustained Viral Response With a Prior Course of Pegylated Interferon and RibavirinStatus: Terminated, Estimated PCD: 2011-01-12
Clinical trial
Betaine METABOLISM OF PATIENTS With HomocystinuriaStatus: Completed, Estimated PCD: 2017-12-01
Organization
Lukare Medical, LLCDocument
DailyMed Label: BetaineOrganization
Cosette Pharmaceuticals, Inc.Document
DailyMed Label: CystadaneOrganization
Recordati Rare Diseases, Inc.